Image
Presented by Sarah Rosenwohl-Mack, MD, MPH, AAHIVS, the speaker will review current guidelines and evidence for long-acting injectable (LAI) buprenorphine in people with opioid use disorder (OUD), as well as emerging evidence and best practices around direct-to-inject buprenorphine initiation.